1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
Treatment of Low Bone Density in Cystic Fibrosis.
|3||Not yet recruiting||
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
† Indicates status has not been verified in more than two years